Home >
Medicine Info >
Altargo Ointment
Loading interface...

Altargo Ointment

Manufactured byGLAXOSMITHKLINE PHARMACEUTICALS LTD
ContainsRetapamulin
Description
Altargo Ointment is an antibacterial agent used for the treatment of bacterial skin infections such as Primary impetigo, secondarily infected traumatic lesions, secondarily infected dermatoses. This medicine not recommended for use in infants below the age of 9 months.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Altargo Ointment

  • Skin Rash
  • Burning sensation of skin
  • Itching
  • Redness of skin
  • Pain at site of application

Uses of Altargo Ointment

What is it prescribed for?

  • Impetigo
  • Dermatoses
  • Secondarily Infected Traumatic Lesions
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to retapamulin or any other inactive ingredients present along with it.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.
General warnings

Use in Children

This medicine is not recommended for use in infants below 9 months of age since the safety and efficacy of use are not clinically established.

Local irritation

Use of this medicine may increase the risk of severe local irritation or sensitization in some patients. In such cases, your doctor may advise you to discontinue the therapy with this medicine. Report any unusual symptoms to the doctor on priority. An alternative treatment option should be considered in some cases based on the clinical condition.

Abscesses

This medicine is not recommended for treating abscesses, which are characterized by pus, painful lump, tenderness, etc. An alternative treatment option should be considered based on clinical condition.

Methicillin-resistant staphylococcus aureus (MRSA)

This medicine is not recommended for treating Methicillin-resistant Staphylococcus aureus (MRSA) infections due to the increased risk of worsening the condition. An alternative treatment option should be considered based on clinical condition.

External Use Only

This medicine is recommended for external use only. Avoid contact with the eyes, mucous membranes, or open wounds.

Missed Dose

Apply the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not apply a double dose to make up for the missed dose.

Overdose

An overdose of this medicine is not likely to cause severe symptoms unless it is applied for a prolonged period of time in large volumes. However, ingestion of this medicine may cause harm and immediate medical intervention may be required.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Amprenavir

Clotrimazole

Nifedipine

Fostamatinib

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Apply a thin layer of the cream/ointment to the affected area as instructed by the doctor. Follow all the usage instructions mentioned on the label or the package insert. Do not apply in larger or smaller quantities than recommended. Do not cover the application area with bandages or other coverings unless specifically instructed by the doctor. Contact your doctor if symptoms do not improve or resolve after 3-4 days of use.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by killing the bacterial growth on the skin.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Topical antibiotics

Schedule

Schedule H

[Internet]. Ema.europa.eu. 2018 [cited 14 September 2018]. Available from:

http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000757/WC500024409.pdf

[Internet]. Ec.europa.eu. 2018 [cited 14 September 2018]. Available from:

http://ec.europa.eu/health/documents/community-register/2010/2010012573309/anx_73309_en.pdf

[Internet]. Accessdata.fda.gov. 2018 [cited 14 September 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022055s002lbl.pdf

[Internet]. Au.gsk.com. 2018 [cited 14 September 2018]. Available from:

https://au.gsk.com/media/212995/altargo_cmi_au_002_approved.pdf

[Internet]. Tga.gov.au. 2018 [cited 14 September 2018]. Available from:

https://www.tga.gov.au/sites/default/files/auspar-retapamulin-131111.pdf

[Internet]. Pdf.hres.ca. 2018 [cited 14 September 2018]. Available from:

https://pdf.hres.ca/dpd_pm/00011986.PDF
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 8 Feb 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.